The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma
Keyword(s):
2014 ◽
Vol 20
(22)
◽
pp. 5796-5807
◽
Keyword(s):
2008 ◽
Vol 141
(5)
◽
pp. 659-671
◽
Keyword(s):
2019 ◽
Vol 19
(10)
◽
pp. e102-e103
Keyword(s):
2019 ◽
Vol 19
(10)
◽
pp. e148-e149
Keyword(s):
2012 ◽
Vol 104
(13)
◽
pp. 964-965
◽